Selected research
Market Outlook & Growth Opportunities
Global Folic Acid Injection Market Outlook and Growth Opportunities 2026
Market perspective
The global Folic Acid Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Folic Acid Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Folic Acid Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Folic Acid Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Folic Acid Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Folic Acid Injection market include Shanghai Pharmaceuticals, Merck & Co, Eli Lilly, Sandoz Canada Incorporated, Ceva Animal Health Australia and Anhui Medipharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Folic Acid Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Folic Acid Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Folic Acid Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Folic Acid Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Folic Acid Injection Segment by Company
Shanghai Pharmaceuticals
Merck & Co
Eli Lilly
Sandoz Canada Incorporated
Ceva Animal Health Australia
Anhui Medipharm
Folic Acid Injection Segment by Type
Folic Acid Inj 5mg/ml
Folic Acid Inj 30mg/2ml
Folic Acid Injection Segment by Application
Adult
Children
Elderly
Folic Acid Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Folic Acid Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Folic Acid Injection market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Folic Acid Injection significant trends, drivers, influence factors in global and regions.
6. To analyze Folic Acid Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Folic Acid Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Folic Acid Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Folic Acid Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Folic Acid Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Folic Acid Injection industry.
Chapter 3: Detailed analysis of Folic Acid Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Folic Acid Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Folic Acid Injection in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Folic Acid Inj 5mg/ml
- Folic Acid Inj 30mg/2ml
Applications
- Adult
- Children
- Elderly
Companies covered
- Shanghai Pharmaceuticals
- Merck & Co
- Eli Lilly
- Sandoz Canada Incorporated
- Ceva Animal Health Australia
- Anhui Medipharm
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Folic Acid Injection Sales Value (2021-2032)
- 1.2.2 Global Folic Acid Injection Sales Volume (2021-2032)
- 1.2.3 Global Folic Acid Injection Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Folic Acid Injection Market Dynamics
- 2.1 Folic Acid Injection Industry Trends
- 2.2 Folic Acid Injection Industry Drivers
- 2.3 Folic Acid Injection Industry Opportunities and Challenges
- 2.4 Folic Acid Injection Industry Restraints
3 Folic Acid Injection Market by Company
- 3.1 Global Folic Acid Injection Company Revenue Ranking in 2025
- 3.2 Global Folic Acid Injection Revenue by Company (2021-2026)
- 3.3 Global Folic Acid Injection Sales Volume by Company (2021-2026)
- 3.4 Global Folic Acid Injection Average Price by Company (2021-2026)
- 3.5 Global Folic Acid Injection Company Ranking (2024-2026)
- 3.6 Global Folic Acid Injection Company Manufacturing Base and Headquarters
- 3.7 Global Folic Acid Injection Company Product Type and Application
- 3.8 Global Folic Acid Injection Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Folic Acid Injection Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Folic Acid Injection Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Folic Acid Injection Market by Type
- 4.1 Folic Acid Injection Type Introduction
- 4.1.1 Folic Acid Inj 5mg/ml
- 4.1.2 Folic Acid Inj 30mg/2ml
- 4.2 Global Folic Acid Injection Sales Volume by Type
- 4.2.1 Global Folic Acid Injection Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Folic Acid Injection Sales Volume by Type (2021-2032)
- 4.2.3 Global Folic Acid Injection Sales Volume Share by Type (2021-2032)
- 4.3 Global Folic Acid Injection Sales Value by Type
- 4.3.1 Global Folic Acid Injection Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Folic Acid Injection Sales Value by Type (2021-2032)
- 4.3.3 Global Folic Acid Injection Sales Value Share by Type (2021-2032)
5 Folic Acid Injection Market by Application
- 5.1 Folic Acid Injection Application Introduction
- 5.1.1 Adult
- 5.1.2 Children
- 5.1.3 Elderly
- 5.2 Global Folic Acid Injection Sales Volume by Application
- 5.2.1 Global Folic Acid Injection Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Folic Acid Injection Sales Volume by Application (2021-2032)
- 5.2.3 Global Folic Acid Injection Sales Volume Share by Application (2021-2032)
- 5.3 Global Folic Acid Injection Sales Value by Application
- 5.3.1 Global Folic Acid Injection Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Folic Acid Injection Sales Value by Application (2021-2032)
- 5.3.3 Global Folic Acid Injection Sales Value Share by Application (2021-2032)
6 Folic Acid Injection Regional Sales and Value Analysis
- 6.1 Global Folic Acid Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Folic Acid Injection Sales by Region (2021-2032)
- 6.2.1 Global Folic Acid Injection Sales by Region: 2021-2026
- 6.2.2 Global Folic Acid Injection Sales by Region (2027-2032)
- 6.3 Global Folic Acid Injection Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Folic Acid Injection Sales Value by Region (2021-2032)
- 6.4.1 Global Folic Acid Injection Sales Value by Region: 2021-2026
- 6.4.2 Global Folic Acid Injection Sales Value by Region (2027-2032)
- 6.5 Global Folic Acid Injection Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Folic Acid Injection Sales Value (2021-2032)
- 6.6.2 North America Folic Acid Injection Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Folic Acid Injection Sales Value (2021-2032)
- 6.7.2 Europe Folic Acid Injection Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Folic Acid Injection Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Folic Acid Injection Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Folic Acid Injection Sales Value (2021-2032)
- 6.9.2 South America Folic Acid Injection Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Folic Acid Injection Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Folic Acid Injection Sales Value Share by Country, 2025 VS 2032
7 Folic Acid Injection Country-level Sales and Value Analysis
- 7.1 Global Folic Acid Injection Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Folic Acid Injection Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Folic Acid Injection Sales by Country (2021-2032)
- 7.3.1 Global Folic Acid Injection Sales by Country (2021-2026)
- 7.3.2 Global Folic Acid Injection Sales by Country (2027-2032)
- 7.4 Global Folic Acid Injection Sales Value by Country (2021-2032)
- 7.4.1 Global Folic Acid Injection Sales Value by Country (2021-2026)
- 7.4.2 Global Folic Acid Injection Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.9.2 France Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.16.2 China Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.19.2 India Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Folic Acid Injection Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Folic Acid Injection Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Folic Acid Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Shanghai Pharmaceuticals
- 8.1.1 Shanghai Pharmaceuticals Company Information
- 8.1.2 Shanghai Pharmaceuticals Business Overview
- 8.1.3 Shanghai Pharmaceuticals Folic Acid Injection Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Shanghai Pharmaceuticals Folic Acid Injection Product Portfolio
- 8.1.5 Shanghai Pharmaceuticals Recent Developments
- 8.2 Merck & Co
- 8.2.1 Merck & Co Company Information
- 8.2.2 Merck & Co Business Overview
- 8.2.3 Merck & Co Folic Acid Injection Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Merck & Co Folic Acid Injection Product Portfolio
- 8.2.5 Merck & Co Recent Developments
- 8.3 Eli Lilly
- 8.3.1 Eli Lilly Company Information
- 8.3.2 Eli Lilly Business Overview
- 8.3.3 Eli Lilly Folic Acid Injection Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Eli Lilly Folic Acid Injection Product Portfolio
- 8.3.5 Eli Lilly Recent Developments
- 8.4 Sandoz Canada Incorporated
- 8.4.1 Sandoz Canada Incorporated Company Information
- 8.4.2 Sandoz Canada Incorporated Business Overview
- 8.4.3 Sandoz Canada Incorporated Folic Acid Injection Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Sandoz Canada Incorporated Folic Acid Injection Product Portfolio
- 8.4.5 Sandoz Canada Incorporated Recent Developments
- 8.5 Ceva Animal Health Australia
- 8.5.1 Ceva Animal Health Australia Company Information
- 8.5.2 Ceva Animal Health Australia Business Overview
- 8.5.3 Ceva Animal Health Australia Folic Acid Injection Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Ceva Animal Health Australia Folic Acid Injection Product Portfolio
- 8.5.5 Ceva Animal Health Australia Recent Developments
- 8.6 Anhui Medipharm
- 8.6.1 Anhui Medipharm Company Information
- 8.6.2 Anhui Medipharm Business Overview
- 8.6.3 Anhui Medipharm Folic Acid Injection Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Anhui Medipharm Folic Acid Injection Product Portfolio
- 8.6.5 Anhui Medipharm Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Folic Acid Injection Value Chain Analysis
- 9.1.1 Folic Acid Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Folic Acid Injection Sales Mode & Process
- 9.2 Folic Acid Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Folic Acid Injection Distributors
- 9.2.3 Folic Acid Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst